hCD83ext protein was analyzed by one-dimensional CD83 is a 45-kDa glycoprotein and member of the NMR and these analyses strongly indicate that immunoglobulin (Ig) superfamily. It is the best known hCD83ext is folded and could therefore be used for marker for mature dendritic cells. Although the pre-further structural and functional studies. ᭧ 2002 Elsevier cise function of CD83 is not known, its selective expres-Science (USA) sion and upregulation together with the costimulators Key Words: CD83; dendritic cells; recombinant CD80 and CD86 suggests an important role of CD83 in expression; monoclonal antibodies. the induction of immune responses. To perform functional studies and to elucidate its mode of action it is vital to obtain recombinant expressed and highly Dendritic cells (DC) 2 are the best antigen presenting purified CD83 molecules. Therefore, the external Ig cells (APC) and since only DC are able to stimulate domain of human CD83 (hCD83ext) was expressed as naive T cells they are also known as "nature's adjuvant" a GST fusion protein (GST-hCD83ext) and the soluble (1)(2)(3). This fact has also led to the use of modified DC protein was purified under native conditions. The for the vaccination of tumor patients, and several enfusion protein was purified using GSTrap columns couraging clinical phase I studies have been reported followed by anion-exchange chromatography. GST- (4, 5). In order to induce potent immune responses DC, hCD83ext was then cleaved using thrombin and soluble which reside in an immature status in the periphery, hCD83ext was further purified using GSTrap columns have to mature. Upon antigen uptake and inflammation and finally by a preparative gel filtration as a polishing DC start to mature and migrate to the T cell areas of step and used for further characterization. The purithe peripheral lymph nodes, where they encounter and fied GST-hCD83 fusion protein was also used to generstimulate rare antigen-specific T cells. During this matate monoclonal anti-CD83 antibodies in a rat system. uration process DC induce and express a whole variety not known, its selective expression and upregulation 1 h at 37ЊC. Then the cells were pelleted and resuspended in 10 ml of native buffer (140 mM NaCl, 2.7 together with the costimulators CD80 and CD86 suggests an important role of CD83 in the induction of mM KCl, 10 mM Na 2 HPO 4 , 1.8 mM KH 2 PO 4 , 2.6 mM MnCl 2 , 26 mM MgCl 2 , 1 g/ml of leupeptin, 1 g/ml of immune responses (6-9). In addition, we have recently shown that by interfering with the translocation of aprotinin, 1 g/ml DNase I, pH 7.6) per 500-ml culture; 50 g/ml of lysozyme was also added. After 15 min mRNA encoding CD83 and thus inhibiting CD83 protein synthesis, the T cell stimulatory capacity of DC incubation on ice the lysate was sonicated at four times 10-s bursts and then spun at 20,000g. Protein purificawas significantly reduced (10). Furthermore, we demonstrated a selective downregulation of the cell surface tion was as follows. In the capture step, 40 ml of supernatant was added to a GSTrap 5-ml column on an Ä KTA expression of CD83 after the infection of mature DC with herpes simplex virus type 1 and a reduced ability Explorer 10 system (Amersham Pharmacia Biotech).
Dendritic cells (DC)
2 are the best antigen presenting purified CD83 molecules. Therefore, the external Ig cells (APC) and since only DC are able to stimulate domain of human CD83 (hCD83ext) was expressed as naive T cells they are also known as "nature's adjuvant" a GST fusion protein (GST-hCD83ext) and the soluble (1-3). This fact has also led to the use of modified DC protein was purified under native conditions. The for the vaccination of tumor patients, and several enfusion protein was purified using GSTrap columns couraging clinical phase I studies have been reported followed by anion-exchange chromatography. GST-(4, 5). In order to induce potent immune responses DC, hCD83ext was then cleaved using thrombin and soluble which reside in an immature status in the periphery, hCD83ext was further purified using GSTrap columns have to mature. Upon antigen uptake and inflammation and finally by a preparative gel filtration as a polishing DC start to mature and migrate to the T cell areas of step and used for further characterization. The purithe peripheral lymph nodes, where they encounter and fied GST-hCD83 fusion protein was also used to generstimulate rare antigen-specific T cells. During this matate monoclonal anti-CD83 antibodies in a rat system. uration process DC induce and express a whole variety Two different monoclonal antibodies were generated.
of different proteins, including molecules for binding to
Using these antibodies, CD83 was specifically recogand stimulation of T cells.
nized in FACS and Western blot analyses. Furthermore, we showed that native CD83 is glycosylated and that
One of the molecules which is specifically and this glycosylation influences the binding of the anti-strongly upregulated on mature DC is CD83. In fact, bodies in Western blot analyses. Finally, the purified CD83 represents the best known marker for mature human DC. Although the precise function of CD83 is not known, its selective expression and upregulation 1 h at 37ЊC. Then the cells were pelleted and resuspended in 10 ml of native buffer (140 mM NaCl, 2.7 together with the costimulators CD80 and CD86 suggests an important role of CD83 in the induction of mM KCl, 10 mM Na 2 HPO 4 , 1.8 mM KH 2 PO 4 , 2.6 mM MnCl 2 , 26 mM MgCl 2 , 1 g/ml of leupeptin, 1 g/ml of immune responses (6-9). In addition, we have recently shown that by interfering with the translocation of aprotinin, 1 g/ml DNase I, pH 7.6) per 500-ml culture; 50 g/ml of lysozyme was also added. After 15 min mRNA encoding CD83 and thus inhibiting CD83 protein synthesis, the T cell stimulatory capacity of DC incubation on ice the lysate was sonicated at four times 10-s bursts and then spun at 20,000g. Protein purificawas significantly reduced (10) . Furthermore, we demonstrated a selective downregulation of the cell surface tion was as follows. In the capture step, 40 ml of supernatant was added to a GSTrap 5-ml column on an Ä KTA expression of CD83 after the infection of mature DC with herpes simplex virus type 1 and a reduced ability Explorer 10 system (Amersham Pharmacia Biotech).
The binding buffer was PBS (140 mM NaCl, 2.7 mM to stimulate allogeneic T cells in mixed leukocyte reactions (11) . These data further suggest an important KCl, 10 mM Na 2 HPO 4 , 1.8 mM KH 2 PO 4 , pH 7.6). The elution buffer was 50 mM Tris-HCl, pH 8.0, with 5 mM role for CD83. CD83 consist of an extracellular Ig-like domain, a short transmembrane region, and a 39-reduced glutathione. The flow rate was 5 ml/min. The chromatographic procedure included 4 CV (column volamino-acid intracellular domain. Recently, the murine CD83 has also been cloned and characterized (12, 13). umes) of binding buffer, 40 ml of supernatant, 12 CV of binding buffer, 5 CV of elution buffer, 5 CV of 2 M Murine CD83 shares 63% amino acid identity with human CD83. The amino acids of its extracellular domain NaCl/PBS, pH 7.6, and 5 CV of binding buffer. For the intermediate purification steps, the GST-hCD83ext show a similarity of 71% to hCD83, while the highest similarity is present in the transmembrane and the containing eluted fractions were pooled and dialyzed against 50 mM 1-methylpiperazine, 50 mM bis-Tris, 25 cytoplasmic domain. These findings suggest a highly conserved function for human and murine CD83.
mM Tris, pH 9.5 (buffer A), and loaded on a Source 15Q PE 4.6/100 anion-exchange column (Amersham PharNevertheless, in order to elucidate the function of CD83 it is vital to obtain recombinant expressed and macia Biotech) on an Ä KTA Explorer 10 system. Proteins were separated by three different linear salt gradihighly purified CD83 molecules. Here we describe the overexpression, purification, and biochemical charac-ents: 16 CV to target concentration 10% buffer B (buffer A/1M NaCl); 20 CV to target concentration 50% buffer terization of the human extracellular CD83 domain. Using native conditions and three purification steps we B; 10 CV to target concentration 100% buffer B. The GST-hCD83ext containing eluted fractions were diawere able to generate large amounts of highly purified protein which is suitable for further functional and lyzed against PBS, pH 7.6. Then the GST-hCD83ext fusion protein was incubated with 20 U/ml of thrombin structural studies.
at 22ЊC for 16 h. To separate the hCD83ext protein from GST, the elution was loaded again on a GSTrap 5-ml EXPERIMENTAL column using the capture step buffer conditions. Under Cloning of the Extracellular Domain of Human binding buffer conditions the flow through containing CD83 (hCD83ext) recombinant human CD83ext protein was collected. For the polishing step, finally a preparative gel filtration The extracellular domain of human CD83 (amino separation was performed loading the flow through onto acids 23-128) was PCR amplified using the following a Superdex 75 (26/16) prep grade column (Amersham primers: sense, pGEX2ThCD83, 5Ј-TCCCCCGGGAA Pharmacia Biotech) on an Ä KTA Explorer 10 system, CGCCGGAGGTGAAGGTGGCT-3Ј; and antisense, running buffer PBS, pH 7.6, flow rate 3 ml/min. CD83extra, 5Ј-AATTAGAATTCTCAAATCTCCGCTC TGTATT-3Ј. The amplified fragment was subcloned Production of Monoclonal Antibodies against into the SmaI and EcoRI sites of the expression vector Human CD83 pGEX2T (Amersham Pharmacia Biotech, Freiburg, Approximately 50 g of the GST-hCD83ext fusion Germany), resulting in the plasmid pGEX2ThCD83ext protein was injected intraperitoneally (ip) and subcutaand transformed into the Escherichia coli strain neously (sc) into LOU/C rats. After a 2-month interval, TOP10FЈ (Invitrogen, Groningen, The Netherlands).
a final boost with the antigen was given ip and sc 3 days The correct insert was verified by sequencing.
before fusion. Fusion of the myeloma cell line P3X63-Ag8.653 with rat immune spleen cells was performed Expression and Purification of hCD83ext according to standard procedure. Hybridoma supernatants were tested in a solid-phase immunoassay using An overnight bacterial culture was diluted 1:10 in fresh LB medium (supplemented with 100 g/ml of am-the GST-hCD83ext protein adsorbed to polystyrene microtiter plates. Following incubation with culture supicillin). At an optical density (600 nm) of 0.9, 1 mM IPTG was added and the culture proceeded for a further pernatants for 1 h, bound monoclonal antibodies were detected with peroxidase-labeled goat antirat IgGϩIgM Generation of Dendritic Cells antibodies (Dianova, Hamburg, Germany) and o-phenyCells were cultured using a standard medium (relenediamine as chromogen in the peroxidase reaction.
ferred to as 1% human plasma medium), which conAn irrelevant GST fusion protein served as a negative sisted of RPMI 1640 (BioWhittaker, Verviers, Belgium) control. The immunoglobulin isotype of the monoclonal supplemented with 300 g/ml of glutamine (BioWhitantibodies was determined using biotinylated antirat taker), 20 g/ml of penicillin/streptomycin, 10 mM immunoglobulin (IgG) subclass-specific monoclonal anHepes, pH 7.5 (Sigma-Aldrich, Deisenhofen, Germany), tibodies (ATCC, Rockville, MD). CD83-1G11 (rat IgG1) and 1% heat-inactivated (56ЊC; 30 min) human plasma and CD83-4B5 (rat IgG2a) were used for Western blot from a single AB donor, obtained from the Department and FACS analysis.
of Transfusion Medicine, Erlangen, Germany. PBMCs were isolated from buffy coats by sedimentation in
Immunoblotting Analyses
Ficoll-Hypaque (Amersham Pharmacia Biotech), seeded onto IgG-coated (10 g/ml of ␥ -globulin from the Cell extracts from mature DC or purified hCD83ext
Cohn fraction; Sigma-Aldrich) 100-mm culture dishes, protein were resuspended in gel loading buffer [50 mM and incubated at 37ЊC in 5% CO 2 . After 1 and 7 h of Tris-HCl (pH 6.8), 2% sodium dodecyl sulfate (SDS), incubation, nonadherent cell fractions were harvested, 10% glycerol, 5% ␤ -mercaptoethanol, 0.1% bromphenol and the remaining adherent cells were further cultured blue] and separated by SDS-polyacrylamide gel elecin 1% human plasma medium supplemented with the trophoresis (PAGE). The proteins were transferred onto cytokines 800 U/ml rhGM-CSF (Leukomax; rh, recomnitrocellulose membranes (Amersham). The membinant human) and 1000 U/ml rhIL-4 (Amedak); 5 ml branes were blocked with 5% dry milk in TBST (150 of fresh medium containing 4000 U of rhGM-CSF and mM NaCl, 10 mM Tris-HCl, pH 8.0, 0.05% Tween 20) 5000 U of IL-4 was added to the culture dish at day 3 at 4ЊC overnight or 1 h at room temperature (RT), incuof the incubation period. On day 4 or 5, nonadherent bated for 1 h at RT with the monoclonal anti-CD83 cells were collected, counted, and transferred into new antibodies (1:1000 CD83-1G11; CD83-4B5 both dedishes at a density of 0.3-0.5 ϫ 10 5 cells/ml. For final scribed in this paper; and 1:800 anti-CD83 from Immu-DC maturation, 1% human plasma medium was supplenotech, Marseilles, France), and washed three times mented with 40 U/ml of rhGM-CSF, 200 U/ml of IL-4, with TBST. Subsequently, the membranes were incu-1.25 ng/ml of rhTNF-␣ (Boehringer, Mannheim, Gerbated for 1 h at RT with the secondary antibody coupled many), 0.5 g/ml of prostaglandin E 2 (Sigma), and 1 to peroxidase. For CD83-1G11 and CD83-4B5 a ng/ml of IL-1␤ (Peprotech). 1:20,000 dilution of the rabbit antirat IgG antibody (Dianova) was used, while for the anti-CD83 antibody from Immunotech, a 1:10,000 dilution of the goat antimouse FACS Analysis IgG antibody (Dianova) was used in TBST plus 5% dry milk. Specific bands were visualized using an enhanced Phenotypic analyses of cells were performed by flow chemiluminescence detection system (Amersham).
cytometry using saturating concentrations of CD83 mAbs (CD83-1G11 and CD83-4B5, both described in this paper, and anti-CD83 from Immunotech). The iso-N-Terminal Amino Acid Sequencing type control IgG2b (Becton-Dickinson, Heidelberg, One portion of the purified extracellular CD83 do-Germany) or rat immune serum was run in parallel. main was applied to PAGE, and the proteins were trans-Cells were analyzed on a FACScan (Becton-Dickinson). ferred to a PVDF membrane (Immobilon-P, Millipore, Nonviable cells were gated out on the basis of their Eschborn, Germany). Proteins were visualized by Pon-light scatter properties. ceau red staining, the only visible band was cut out, and N-terminal amino acid sequencing was performed by automated gas phase Edman degradation (Toplab, Glycosylation Assay Martinsried, Germany).
Lysates of mature DC were incubated with Peptide N-Glycosidase F (PNGaseF) (New England Biolabs,
1D-NMR Studies
Schwalbach, Germany) for 1 h at 37ЊC in the supplied buffer according to the manufacturer's instructions. One-dimensional (1-D) 1 H-NMR spectra of a 0.7 mM sample of extracellular CD83 domain were recorded at Proteins were separated by SDS-polyacrylamide gel electrophoresis and blotted onto nitrocellulose mem-300 K, pH 6.5, in H 2 O/D 2 O (9:1, v/v) on a Bruker DRX600 spectrometer operating at a proton resonance brane (Amersham). The specific immunodetection was performed with the three anti-CD83 monoclonal antifrequency of 600 MHz with a spectral width of 9615.4 Hz and excitation sculpting (14) for water suppression. bodies described above. 
Allogenic T Cell Proliferation
donor in 96-well plates. DC were treated with different concentrations of the newly generated monoclonal antiHuman PBMC were isolated from buffy coats and CD83 antibodies CD83-1G11 and CD83-4B5 and incuthe T cell fraction was purified by rosetting with neubated for 4 days at 37ЊC. Rat immune serum was used ramidase-treated sheep red blood cells as described by as a negative control. Then the cells were pulsed with Bender et al. using an ICH-110 harvester (Inotech, Dottikon, Swit-50 mM 1-methylpiperazine, 50 mM bis-Tris, 25 mM Tris, pH 9.5, as a broad range buffer and a three-step zerland), and [ 3 H]thymidine incorporation was determined using a microplate counter (Wallac).
linear NaCl gradient for elution (Fig.1B) . The collected protein fraction was dialyzed against PBS and concentrated by another affinity chromatography over a
RESULTS AND DISCUSSION
GSTrap column. This purified fusion protein was then Recombinant Expression, Purification, and used for the generation of monoclonal antibodies and Characterization of hCD83ext for thrombin cleavage. For functional studies hCD83ext had to be cleaved The coding region of the extracellular human CD83 domain (hCD83ext; amino acids 23-128) was amplified with thrombin from its fusion partner GST. After incubation with thrombin the cleavage products were by PCR and cloned into the pGEX-2T vector, generating the plasmid pGEX2T-hCD83ext. This plasmid has an loaded onto a GSTrap column and hCD83ext was collected in the flow through while GST was bound to the IPTG inducible tac promotor and a thrombin protease recognition site for cleaving the hCD83ext domain from column (Fig. 1C) . As a final polishing step HPLC gel filtration chromatography was applied using a Superthe GST fusion partner. TOP10FЈ cells were transformed with plasmid pGEX2T-hCD83ext for the expres-dex 75 (26/16) prep grade column. The final yield of purified hCD83ext was 8 mg per 10 liters of culture. The sion of the GST-hCD83ext fusion protein. Native purification conditions were used to obtain a correctly folded purity was confirmed by SDS-PAGE analysis under reducing conditions and in addition by Western blot and purified protein without the need of refolding steps. Affinity chromatography with GST-tagged fusion pro-analyses using commercially available anti-CD83 antibody (Fig. 1D) . Comparable results were obtained with teins simplifies purification of large yields of recombinant proteins under mild conditions. Nevertheless, over the two rat anti-CD83 monoclonal antibodies (CD83-1G11 and CD83-4B5) described in this paper (see Fig.  80% of the fusion product was expressed in inclusion bodies. To reduce the amount of recombinant protein 4). Amino-terminal amino acid sequencing analyses further confirmed the correct identity of the purified procontained within inclusion bodies, the IPTG controlled expression was induced at an OD of 0.9 for the short tein (data not shown).
In order to determine whether the recombinant protime period of 30 to 60 min. Using these conditions yields of 4-5 mg of soluble purified GST-hCD83ext per tein was folded, one-dimensional NMR studies were performed. The 1-D NMR spectrum of hCD83ext at 300 liter of E. coli culture were achieved.
The fusion protein was first purified using GSTrap K showed the chemical dispersion typical of a structured protein (Fig. 2) . The large dispersion of the amide columns and the collected fractions were analyzed by PAGE and Western blotting (Fig. 1A) . Next, an anion-proton resonances (ϳ7.7 to 9.7 ppm) and the presence of C ␣ proton resonances downfield from the water signal exchange chromatography step was performed using FSC-H, forward scatter). (A) Mature DC at day 7. CD83-1G11 (7 g/ml (rat IgG1)) (C) and CD83-4B5 (7 g/ml (rat IgG2a)) (D) detected specifically CD83 on mature DC. A commercially available anti-CD83 antibody (12.5 g/ml) (B) (Immunotech) was used as a positive control. The specific antibodies are shown in bold lines, and the individual isotype controls are shown as dotted lines.
(ϳ4.8 to 5.7 ppm) indicate the presence of a ␤ -sheet-The two specific clones CD83-1G11 (rat IgG1) and CD83-4B5 (rat IgG2a) were used for further investigatype secondary structure consistent with the expected Ig-like structure. Upfield-shifted methyl resonances tions. Both antibodies could specifically detect CD83 on mature DC in FACS analysis, although CD83-4B5 (␦ Ͻ 0.7 ppm) provide further evidence of the protein being folded. These NMR data strongly support that showed a higher sensitivity when compared with CD83-1G11 and the commercially available anti-CD83 antithe recombinant expressed hCD83ext adopts a defined three-dimensional structure and relevant functional body (Fig. 3) . studies can be performed using this protein.
CD83 Expressed on Mature Human DC Is Generation and Testing of Anti-CD83 Antibodies
Glycosylated LOU/C rats were immunized with the fusion protein
The two new antibodies (CD83-4B5 and CD83-1G11) GST-hCD83ext. To produce monoclonal antibodies, also specifically detected the recombinant hCD83ext spleen cells of the immunized rats were fused with the protein in Western blot analyses when used at a dilution myeloma cell line P3X63-Ag8.653 after 2 months. The of 1:1000 (Fig. 4A) . In contrast, when cellular lysates supernatants were tested in an immunoassay using the of mature DC were analyzed only weak signals, in mul-GST-hCD83ext fusion protein as a positive control and tiple bands between 38 and 50 kDa, were observed when an irrelevant GST fusion protein as a negative control. proteins were separated using PAGE under reducing conditions. Similar results were achieved with the commercially available antibody. These different bands, observed between 38 and 50kDa, could be due to protein degradation or may represent different glycosylation products. Indeed, in a previous report we showed that murine CD83 is in fact glycosylated (13) .
As shown in Fig. 4B human CD83 is also glycosylated since after digestion with PNGase F the CD83-specific multiple bands shifted down to a single lower mass band corresponding to the molecular weight of unglycosylated CD83. These data clearly prove that CD83 is glycosylated in mature DC. Interestingly, the binding affinity of CD83-1G11 strongly increased after PNGase treatment, indicating that this posttranslational modification interferes with the antibody detection in this which is only exposed once CD83 is deglycosylated.
In conclusion, we report here the expression, purification, and biochemical characterization of the extracellular domain of human CD83. The initial NMR data suggest that hCD83ext could be used for further functional and structural studies. In addition, two new monoclonal anti-CD83 antibodies, CD83-1G11 and CD83-4B5, were generated using the recombinantly expressed protein. CD83-4B5 is a clear alternative to FACS analysis, while CD83-1G11 could be used for immunoblot studies. Thus, these are very useful tools for further mechanistic studies. Experiments regarding this topic are ongoing in our laboratory. These antibody reagents, combined with recombinant hCD83ext, will help to define the functional role of CD83 and to better understand the development of DC and their role in the interaction 
